The Board of Directors of Godavari Drugs Limited, at its meeting held on 14th October, 2026, approved availing of Working Capital Limits up to Rs. 340 Million from ICICI Bank Limited and authorised the Managing Director to complete the necessary formalities. The outcome is enclosed.

GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice: +91-40-2784 9700/ 2784 2602/ 2784 4557 Email: info@godavaridrugs.com / Website: www.godavaridrugs.com To, Date: 14.10.2026 BSE Limited, P.J. Towers, Dalal Street, Mumbai – 400001 Dear Sir/Madam Unit: Godavari Drugs Limited (Scrip Code: 530317) Sub: Outcome of Board Meeting held on 14.10.2026 With reference to the subject cited this is to inform the Exchange that the Board of Directors of Godavari Drugs Limited, at its Meeting held on Wednesday, 14th October, 2026 at the Registered Office of the Company situated at 1-8-303/34, Mayfair, S.P. Road, Secunderabad, Telangana – 500003, inter alia, considered and approved the following: 1. Availing of Working Capital Limits aggregating up to Rs. 340.00 Million (Rupees Three Hundred and Forty Million only) from ICICI Bank Limited, on the terms and conditions set out in the Credit Arrangement Letter dated 12th October, 2026 issued by ICICI Bank Limited, together with such temporary overdraft facility and/or temporary accommodation as may be sanctioned by the Bank in case of exigencies, and the creation of security for the said facilities in the manner stipulated by the Bank. 2. Authorisation to Mr. Mukund Kakani, Managing Director (DIN: 00104646), to accept the Credit Arrangement Letter, negotiate, finalise and execute the facility and security documents, and to do all such acts, deeds and things as may be necessary to give effect to the above. The said facilities are within the borrowing limits approved by the Members of the Company under Section 180(1)(c) of the Companies Act, 2013 by way of a Special Resolution passed at the Annual General Meeting held on 16th May, 2022. The meeting commenced at 04:00 p.m. and concluded at 04:30 p.m. This is for the information and records of the Exchange, please Thanking you. Yours faithfully, For Godavari Drugs Limited Venkatesh Achanta Company Secretary & Compliance Officer Plant: A6/2, MIDC, Nanded – 431603, Maharastra, India. Email: nnd@godvaridrugs.com CIN: L24230TG1987PLC008016